Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evotec SE (EVO) Total Liabilities (2019 - 2025)

Evotec SE (EVO) has disclosed Total Liabilities for 7 consecutive years, with $1.0 billion as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 2.15% to $1.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 billion through Dec 2025, up 2.15% year-over-year, with the annual reading at $1.0 billion for FY2025, 2.15% up from the prior year.
  • Total Liabilities hit $1.0 billion in Q4 2025 for Evotec SE, up from $1.0 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $1.0 billion in Q4 2025 to a low of $312195.7 in Q4 2022.
  • Historically, Total Liabilities has averaged $415.1 million across 5 years, with a median of $1.3 million in 2021.
  • Biggest five-year swings in Total Liabilities: plummeted 83.41% in 2021 and later skyrocketed 306467.23% in 2024.
  • Year by year, Total Liabilities stood at $1.3 million in 2021, then tumbled by 75.26% to $312195.7 in 2022, then grew by 7.18% to $334617.3 in 2023, then surged by 306467.23% to $1.0 billion in 2024, then grew by 2.15% to $1.0 billion in 2025.
  • Business Quant data shows Total Liabilities for EVO at $1.0 billion in Q4 2025, $1.0 billion in Q4 2024, and $334617.3 in Q4 2023.